TTC7B
Tetratricopeptide repeat protein 7B
Also known as: TTC7B_HUMAN, TTC7L1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86TV6
- Gene
- TTC7B
- Ensembl
- ENSG00000165914
- Chromosome
- 14
- Canonical length
- 843 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Involved in phosphatidylinositol phosphate biosynthetic process and protein localization to plasma membrane. Located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
843 residues, UniProt reviewed canonical sequence.
>Q86TV6|TTC7B
1 MATKKAGSRL ETEIERCRSE CQWERIPELV KQLSAKLIAN DDMAELLLGE SKLEQYLKEH
61 PLRQGASPRG PKPQLTEVRK HLTAALDRGN LKSEFLQESN LIMAKLNYVE GDYKEALNIY
121 ARVGLDDLPL TAVPPYRLRV IAEAYATKGL CLEKLPISSS TSNLHVDREQ DVITCYEKAG
181 DIALLYLQEI ERVILSNIQN RSPKPGPAPH DQELGFFLET GLQRAHVLYF KNGNLTRGVG
241 RFRELLRAVE TRTTQNLRMT IARQLAEILL RGMCEQSYWN PLEDPPCQSP LDDPLRKGAN
301 TKTYTLTRRA RVYSGENIFC PQENTEEALL LLLISESMAN RDAVLSRIPE HKSDRLISLQ
361 SASVVYDLLT IALGRRGQYE MLSECLERAM KFAFEEFHLW YQFALSLMAA GKSARAVKVL
421 KECIRLKPDD ATIPLLAAKL CMGSLHWLEE AEKFAKTVVD VGEKTSEFKA KGYLALGLTY
481 SLQATDASLR GMQEVLQRKA LLAFQRAHSL SPTDHQAAFY LALQLAISRQ IPEALGYVRQ
541 ALQLQGDDAN SLHLLALLLS AQKHYHDALN IIDMALSEYP ENFILLFSKV KLQSLCRGPD
601 EALLTCKHML QIWKSCYNLT NPSDSGRGSS LLDRTIADRR QLNTITLPDF SDPETGSVHA
661 TSVAASRVEQ ALSEVASSLQ SSAPKQGPLH PWMTLAQIWL HAAEVYIGIG KPAEATACTQ
721 EAANLFPMSH NVLYMRGQIA ELRGSMDEAR RWYEEALAIS PTHVKSMQRL ALILHQLGRY
781 SLAEKILRDA VQVNSTAHEV WNGLGEVLQA QGNDAAATEC FLTALELEAS SPAVPFTIIP
841 RVLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TTC7B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 106 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 106 nTPM
- cerebral cortex: 92 nTPM
- amygdala: 68 nTPM
- hippocampal formation: 66 nTPM
- skeletal muscle: 58 nTPM
- basal ganglia: 51 nTPM
Single-cell type
- syncytiotrophoblasts: 382 nCPM
- retinal ganglion cells: 348 nCPM
- retinal amacrine cells: 261 nCPM
- myonuclei: 235 nCPM
- brain excitatory neurons: 232 nCPM
- platelets: 210 nCPM
Immune cell
- eosinophil: 8.1 nTPM
- basophil: 5.6 nTPM
- neutrophil: 0.9 nTPM
- T-reg: 0.9 nTPM
- intermediate monocyte: 0.5 nTPM
- total PBMC: 0.5 nTPM
Brain region
- cerebral cortex: 159 nTPM
- hippocampal formation: 147 nTPM
- cerebellum: 140 nTPM
- thalamus: 136 nTPM
- amygdala: 130 nTPM
- basal ganglia: 130 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.09
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TTC7B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TTC7B as an antibody target. Whether an autoantibody or antibody against TTC7B could matter depends on whether native TTC7B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TTC7B is annotated at the cell surface, where native TTC7B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TTC7B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...